Author:
Hu G.,Gong L. L.,Chen Y. J.,Xu L. H.,Ye C. M.
Reference57 articles.
1. Yeo, B., Turner, N., and Jones, A., An update on the medical management of breast cancer, BMJ, 2014, vol. 348, p. g3608.
2. Helleday, T., Petermann, E., Lundin, C., et al., DNA repair pathways as targets for cancer therapy, Nat. Rev. Cancer, 2008, vol. 8, no. 3, pp.193—204.
3. Matta, J., Echenique, M., Negron, E., et al., The association of DNA repair with breast cancer risk in women: a comparative observational study, BMC Cancer, 2012, vol. 12, p. 490.
4. Lunn, R.M., Langlois, R.G., Hsieh, L.L., et al., XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency, Cancer Res., 1999, vol. 59, no. 11, pp. 2557—2561.
5. Vijg, J. and Dollé, M.E., Large genome rearrangements as a primary cause of aging, Mech. Ageing Dev., 2002, vol. 123, no. 8, pp. 907—915. https://doi.org/10.1016/s0047-6374(02)00028-3